Product image of Gopten (Trandolapril) supplied by GNH India

Gopten

Active Ingredient:
Trandolapril
Origin:
EU

Gopten (Trandolapril)

Gopten is a medication that contains the active ingredient trandolapril, an ACE inhibitor, supplied in oral form. It is marketed in the European Union and classified as an antihypertensive drug. The product is intended for use under medical supervision to manage conditions such as high blood pressure and certain types of heart failure. Trandolapril blocks the conversion of angiotensin I to angiotensin II, helping to relax blood vessels.

Manufacturer / TM Owner

Viatris Sia

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Gopten, containing trandolapril, is used in clinical practice for several cardiovascular indications.

  • Treatment of essential hypertension (high blood pressure).
  • Management of chronic heart failure to improve symptoms and reduce hospitalizations.
  • Adjunct therapy after myocardial infarction to lower risk of subsequent cardiac events.
  • Use in patients with left ventricular dysfunction where ACE inhibition is indicated.
  • May be prescribed as part of combination therapy with diuretics or other antihypertensive agents.

Side Effects

Side effects reported with trandolapril vary in frequency and severity.

Common

  • Cough.
  • Dizziness or light‑headedness, especially after the first dose.
  • Headache.
  • Fatigue.
  • Nausea or mild gastrointestinal upset.

Serious

  • Angioedema (swelling of face, lips, tongue, or throat).
  • Significant drop in blood pressure (hypotension).
  • Acute kidney injury or worsening renal function.
  • Hyperkalemia (elevated blood potassium).

Precautions & Warnings

Before starting Gopten, healthcare providers should evaluate several safety considerations.

  • Assess renal function and serum electrolytes, especially potassium levels.
  • Review history of angioedema, cough, or hypersensitivity to ACE inhibitors.
  • Use cautiously in patients with volume depletion, low blood pressure, or on diuretics.
  • Avoid in pregnancy; trandolapril is contraindicated in the second and third trimesters.
  • Monitor blood pressure regularly after initiating therapy or adjusting the dose.
  • Consider dose adjustment in elderly patients or those with hepatic impairment.

Avoid Interactions

Trandolapril may interact with other medicines, influencing its effectiveness or safety.

Avoid

  • Concomitant use with aliskiren in patients with diabetes or renal impairment.
  • Potassium‑sparing diuretics or potassium supplements that can cause hyperkalemia.
  • NSAIDs (e.g., ibuprofen, naproxen) that may reduce antihypertensive effect and impair renal function.

Use with caution

  • Other antihypertensive agents (beta‑blockers, calcium channel blockers) may increase risk of hypotension.
  • Lithium, as ACE inhibitors can raise lithium levels.
  • Diuretics, especially loop or thiazide types, may enhance blood pressure lowering.

Frequently Asked Questions

Trandolapril inhibits the angiotensin‑converting enzyme (ACE), reducing the conversion of angiotensin I to angiotensin II, which leads to vasodilation and decreased aldosterone secretion.

By blocking ACE, trandolapril reduces angiotensin II levels, causing blood vessels to relax and lowering peripheral resistance, which decreases blood pressure.

Gopten is contraindicated in pregnancy (especially second and third trimesters), in patients with a history of angioedema related to ACE inhibitors, and in those with severe renal impairment.

Common side effects include a persistent dry cough, dizziness or light‑headedness, headache, fatigue, and mild gastrointestinal upset such as nausea.

No. Trandolapril is classified as pregnancy category D and is contraindicated during the second and third trimesters because of risk to the fetus.

Baseline serum creatinine and estimated glomerular filtration rate (eGFR) should be measured before starting therapy, and periodic monitoring is recommended, especially after dose changes.

Avoid using trandolapril with aliskiren in diabetic or renally impaired patients, with potassium‑sparing diuretics or supplements that may cause hyperkalemia, and with NSAIDs that can impair renal function.

Combining trandolapril with a diuretic is common, but blood pressure and electrolytes should be monitored closely because the combination can increase the risk of hypotension and electrolyte disturbances.

ACE inhibitors like trandolapril can increase bradykinin levels in the respiratory tract, which may trigger a dry, persistent cough in some patients.

Trandolapril can reduce aldosterone secretion, leading to potassium retention; therefore, serum potassium should be monitored, especially when used with potassium‑sparing agents.

Facial swelling may indicate angioedema, a serious reaction. The patient should seek immediate medical attention and discontinue the medication.

Blood pressure should be measured within the first week after initiation or dose adjustment, and then regularly (e.g., weekly to monthly) until the target range is achieved.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Trandolapril

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT